Bpifrance SA - Q2 2023 holdings

$3.72 Billion is the total value of Bpifrance SA's 7 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 12.5% .

 Value Shares↓ Weighting
STLA  STELLANTIS NV$3,357,019,015
-4.2%
192,703,9070.0%90.18%
-0.0%
CSTM  CONSTELLIUM NVcl a$281,975,132
+12.6%
16,393,9030.0%7.58%
+17.5%
CRTO SellCRITEO S Aspons ads$60,745,530
-28.5%
1,800,401
-33.2%
1.63%
-25.3%
 MIRION TECHNOLOGIES INC$10,870,469
-1.1%
1,286,4460.0%0.29%
+3.2%
SQNS  SEQUANSCOMMUNICATIONS S Aspons ads$7,359,040
+11.5%
3,300,0180.0%0.20%
+16.5%
CLLS  CELLECTIS S.A.$4,302,844
+1.9%
2,186,9600.0%0.12%
+6.4%
 GETAROUND INC$226,733
+22.8%
647,8080.0%0.01%
+20.0%
VECT ExitVECTIVBIO HOLDING AG$0-2,806,217
-100.0%
-0.61%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-07-28
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings